ConductScience.org, home

Paper12115

Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.

Hansson L and 1 other. Int J Clin Pharmacol Biopharm, 1976. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent. Papers, record 12115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12115

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
PubMed
Journal
Int J Clin Pharmacol Biopharm
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hansson LL
2Hänel BB

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
SympatholyticsMajor topic
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Adult
Blood Pressure
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Posture

Source PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
7,371,699Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7371699PubMed
6,124,264Labetalol in essential hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6124264PubMed
25,757Labetalol: a review of its pharmacology and therapeutic use in hypertension.Drugs1978https://conductscience.org/library/papers/25757PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12115

GET https://conductscience.org/api/papers/v1/12115/authors